Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer of Rocket Pharmaceuticals, sold shares to cover tax obligations related to vesting Restricted Stock Units.
Summary
- On February 21, 2025, John Militello, an officer at Rocket Pharmaceuticals, sold 2,737 shares of common stock at a price of $10.58 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Militello directly owns 65,757 shares of Rocket Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares to cover taxes is a normal occurrence and doesn't necessarily reflect a positive or negative sentiment towards the company's future prospects.
Industry Context
This is a routine Form 4 filing, which is common when company executives sell shares, especially to cover tax obligations related to equity compensation. It doesn't necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 02/21/2025 | Date of the transaction (sale of shares). |
| 02/25/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.